Adolescentsâ?? Resilience and Treatment Needs for Mental Health in Indian Slums

Conditions

Health Condition 1: F949- Childhood disorder of social functioning, unspecified

Maulik PK, Yatirajula SK, Kallakuri S, Paslawar S, Ghosh A, Rastogi A, Mukherjee A, Khan R, Sagar R, Lempp H, Kumar A, Billot L, Essue BM, Chatterjee S, Singh R, Peiris D, Norton R, Thornicroft G.

2026-04-29

10.1001/jamapsychiatry.2026.0603

Protocol for process evaluation of ARTEMIS cluster randomised controlled trial: an intervention for management of depression and suicide among adolescents living in slums in India

Ankita Mukherjee, Sandhya Kanaka Yatirajula, Sudha Kallakuri, Srilatha Paslawar, Heidi Lempp et al. (14 authors)

BMJ Open2024-05-011 citations

10.1136/bmjopen-2023-081844

Using formative research to inform a mental health intervention for adolescents living in Indian slums: the ARTEMIS study.

Mukherjee A, Yatirajula SK, Kallakuri S, Paslawar S, Lempp H, Raman U, Essue BM, Sagar R, Singh R, Peiris D, Norton R, Thornicroft G, Maulik PK.

2024-01-203 citations

10.1186/s13034-024-00704-4

Learnings From Implementation of Technology-Enabled Mental Health Interventions in India: Implementation Report

Sudha Kallakuri, Sridevi Gara, Mahesh Godi, Sandhya Kanaka Yatirajula, Srilatha Paslawar et al. (8 authors)

JMIR Medical Informatics2023-11-294 citations

10.2196/47504

An intervention to reduce stigma and improve management of depression, risk of suicide/self-harm and other significant emotional or medically unexplained complaints among adolescents living in urban slums: protocol for the ARTEMIS project

Sandhya Kanaka Yatirajula, Sudha Kallakuri, Srilatha Paslawar, Ankita Mukherjee, Amritendu Bhattacharya et al. (17 authors)

Trials2022-07-2921 citations

10.1186/s13063-022-06539-8

Interventions

Intervention1: Anti-stigma and mhealth: Optimisation of anti stigma and mhealth intervention a.Antistigma component: System level interventions that reduce stigma, and upskill community health workers

Eligibility

Inclusion criteria

Inclusion criteria: All consenting adolescents in the age group of 10 â?? 19 years will be eligible for screening for CMDs to identify both a high risk and low risk cohort. Informed consent will be sought from all adult participants, and assent sought from minor participants following consent from their guardians. To be eligible for the high risk cohort participants must have at least one of the following: 1.High risk of depression based on a Patient Health Questionnaire-9 item (PHQ9) score >= 10 2.Positive response ( score >=2) to the suicide risk question on the PHQ-9

Exclusion criteria

Exclusion criteria: 1.Participants with severe ill-health that would prevent regular follow-up 2.Adolescents or their guardians do not provide informed written consent 3.Participants who are temporary residents of the slums

Design outcomes

Primary

Measure	Time frame
1. To change the mean behaviour scores at the end of the trial using the KAB scale 2. To assess the proportion of high risk achieving remission at end of trialTimepoint: 12 months	—

Secondary

Measure	Time frame
1.To change mean knowledge and attitude scores and change stigma perceptions of adolescents as assessed by BACE â?? TS Subscale 2.To change baseline mean stigma scores across both high and low risk cohorts 3. To assess standardised mean difference in PHQ-9 scores at end of trial 4.To assess the proportion at high risk of CMDs who have visited a doctor at least once between randomization and the end of the trial.Timepoint: 12 months	—

Measure

Time frame

1.To change mean knowledge and attitude scores and change stigma perceptions of adolescents as assessed by BACE â?? TS Subscale 2.To change baseline mean stigma scores across both high and low risk cohorts 3. To assess standardised mean difference in PHQ-9 scores at end of trial 4.To assess the proportion at high risk of CMDs who have visited a doctor at least once between randomization and the end of the trial.Timepoint: 12 months

—

Countries

India

Contacts

Public ContactDr Pallab Maulik

George Institute For Global health

pmaulik@georgeinstitute.org.in911141588091

Outcome results

None listed